Knight Therapeutics Inc KHTRF:OTCPK

RT Quote | Exchange | USD
Last | 08/16/22 EDT
4.71UNCH (UNCH)
52 week range
3.66 - 4.77
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.71
  • 52 Week High4.77
  • 52 Week High Date08/16/22
  • 52 Week Low3.66
  • 52 Week Low Date12/27/21

Key Stats

  • Market Cap538.04M
  • Shares Out114.62M
  • 10 Day Average Volume7,512
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change13.16

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close4.71
  • 52 Week High4.77
  • 52 Week High Date08/16/22
  • 52 Week Low3.66
  • 52 Week Low Date12/27/21
  • Market Cap538.04M
  • Shares Out114.62M
  • 10 Day Average Volume7,512
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change13.16

RATIOS/PROFITABILITY

  • EPS (TTM)-0.21
  • P/E (TTM)-22.02
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Knight Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. The Company’s products include BIJUVA Estradiol and Progesterone capsule, IMVEXXY Estradiol vaginal inserts, IBSRELA Tenapanor tablets, TRELSTAR Prostate Triptorelin, TRELSTAR...
James Gale
Independent Chairman of the Board
Jonathan Goodman
Chief Executive Officer, Director
Samira Sakhia CPA
President, Chief Operating Officer, Director
Arvind Utchanah
Chief Financial Officer
Jeff Martens
Global Vice President - Commercial
Address
3400 De Maisonneuve Blvd W
Montreal, QC
H3Z 3B8
Canada